Stock Analiz

Journey Medical Corp (DERM) stock forecast and price target

Price $4.33 · data as of November 13, 2026

12-month price target

Average target$13.33
Upside / downside+207.9%
Analysts3
ConsensusStrong buy
Low $13.00Average $13.33High $14.00

Gold marker: average target · white marker: today’s price ($4.33)

Analyst ratings

Strong buy 0Buy 3Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.07—$73M
Next fiscal year
ends December 31, 2027
$0.41—$101M
Next quarter
ends December 31, 2026
$0.03—$19M
Quarter after
ends March 31, 2027
$0.01—$21M

Consensus of the analysts covering Journey Medical, updated daily. In the last 30 days 0 estimates were raised and 2 lowered.

Our model vs. Wall Street

Analysts see 207.9% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Journey Medical’s intrinsic value about 36% below today’s market value, and it scores 0.2 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Journey Medical stock price target?

The average 12-month target from 3 analysts is $13.33, 207.9% above the current price of $4.33 Targets range from $13.00 to $14.00.

Is Journey Medical a buy according to analysts?

The consensus rating is “Strong buy” (3 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Journey Medical expected to earn?

Analysts expect EPS of $-0.07 for the fiscal year ending December 31, 2026 and $0.41 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.